General Information of the Compound
| Compound ID |
CP0452254
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[3beta-(4-Chloro-phenyl)tropane-2beta-carbonyl-oxy]-7-[4-(3beta-{4-chloro-phenyl}tropane-2beta-carbonyl-oxy-methyl)-(1,2,3)triazol-1-yl]heptane
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C40H51Cl2N5O4
|
||||||||||||||||||
| Molecular Weight |
736.785
|
||||||||||||||||||
| Canonical SMILES |
CN1C2CCC1[C@@H]([C@H](C2)c1ccc(Cl)cc1)C(=O)OCCCCCCCn1cc(COC(=O)[C@@H]2C3CCC(C[C@@H]2c2ccc(Cl)cc2)N3C)nn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C40H51Cl2N5O4/c1-45-31-16-18-35(45)37(33(22-31)26-8-12-28(41)13-9-26)39(48)50-21-7-5-3-4-6-20-47-24-30(43-44-47)25-51-40(49)38-34(27-10-14-29(42)15-11-27)23-32-17-19-36(38)46(32)2/h8-15,24,31-38H,3-7,16-23,25H2,1-2H3/t31?,32?,33-,34-,35?,36?,37-,38+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DEQWDXVSVPRQSI-PAASSLRSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter